Literature Collection

OBJECTIVE: The purpose of this study was to understand the barriers and facilitators that affect engagement with Project ECHO (Extension for Community Healthcare Outcomes) to implement medication-assisted treatment (MAT) in primary care settings. METHODS: A 12-session weekly curriculum was delivered to participating primary care providers and clinic staff (N=24 participants from 13 clinics). Participants completed attendance logs and a qualitative interview in order to identify factors that influence engagement in the ECHO sessions and the potential integration of MAT. RESULTS: Primary care providers and staff valued the ECHO sessions, but overall attendance was low and variable. Participants generally valued the didactic and interactive nature of the sessions but identified system-level constraints that limited engagement. Major barriers to participation included competing demands in patient care and the low degree of endorsement by clinic leadership. CONCLUSIONS: This brief report identifies key systematic challenges that may directly limit primary care providers' engagement in telementoring models such as Project ECHO.

Background: Clinic-imposed barriers can impede access to medication for opioid use disorder (MOUD). We evaluated a low-barrier buprenorphine program that is co-located with a syringe services program (SSP) in Seattle, Washington, USA. Methods: We analyzed medical record data corresponding to patients who enrolled into the buprenorphine program in its first year of operation. We used descriptive statistics and tests of association to longitudinally evaluate retention, cumulative number of days buprenorphine was prescribed, and toxicology results. Results: Demand for buprenorphine among SSP clients initially surpassed programmatic capacity. Of the 146 enrolled patients, the majority (82%) were unstably housed. Patients were prescribed buprenorphine for a median of 47 days (interquartile range [IQR] = 8-147) in the 180 days following enrollment. Between the first and sixth visits, the percentage of toxicology tests that was positive for buprenorphine significantly increased (33% to 96%, P < .0001) and other opioids significantly decreased (90% to 41%, P < .0001) and plateaued thereafter. Toxicology test results for stimulants, benzodiazepines, and barbiturates did not significantly change. Conclusions: SSP served as an effective point of entry for a low-barrier MOUD program. A large proportion of enrolled patients demonstrated sustained retention and reductions in opioid use, despite housing instability and polysubstance use.

Integrating behavioral health into primary care can increase patient access to treatments for behavioral health disorders, especially in rural areas. The first step of integrated care implementations is the need to identify at-risk patients and effectively communicate patient screening results to the care team. The use of technology can facilitate patient screening and incorporate screening data into electronic health records. This paper describes the development of a tablet-based screening system to facilitate behavioral health integration in a rural primary care clinic, discusses the preliminary impact of digital screening on workflows, and provides recommendations for the use of technology for screening. A tablet-based assessment was developed to screen patients for behavioral health concerns and was implemented within a rural primary care clinic. The system was created using the Visual Signature Capture system, which integrates directly with the electronic health record. Following the initial assessment, patients are screened as frequently as every 30 days with a mini-screen assessment, consisting of multiple screening tools for mental health and substance use. The tablet-based screening system had a positive impact on clinician workflows and the overall effectiveness of clinic operations. This system supports providers in addressing the behavioral health needs of patients that often go unrecognized in primary care.